Our experts will present at 11 events at the upcoming ISPOR Europe 2025 Conference in Glasgow, contributing to a range of sessions that cover subjects including performance-based arrangements, managed entry agreements, health technology assessment, vaccine value, and drug repurposing policy.
Short Courses, Issue Panels and Research Podiums:
🔸Sunday, 9 November (8:00–12:00)
Short Course: Risk-Sharing/Performance-Based Arrangements in Developing Countries
🔸Monday, 10 November (10:15–11:15)
Issue Panel: Managed Entry Agreements: Can CEE Countries Mutualize Lessons Learned?
🔸Tuesday, 11 November (10:15–11:15)
Member Group Meetings: Bridging the Access Gap: Addressing Differences in Innovative Medicine Access in CEE Countries
🔸Tuesday, 11 November (11:45–12:45)
Issue Panel: Joint Clinical Assessment (JCA) in Practice: Strengthening EU HTA Through CEE Expertise and Patient Perspectives
🔸Tuesday, 11 November (15:15–16:15)
Issue Panel: Vaccine Value Assessment in CEE Countries: Challenges and Opportunities
🔸Wednesday, 12 November (8:00–9:00)
Research Podium: Catalogue of Actions to Address Policy Barriers of Drug Repurposing
Posters:
🔸From Pain to Patient Preferences: Patient Engagement in Early HTA for Repurposing Losartan in Osteogenesis Imperfecta (Mon, 10 Nov – Poster Session 2)
🔸Early Stage Health Economic Evaluation of IMMUTOL Gene Therapy for Relapsing/Remitting Multiple Sclerosis (Tue, 11 Nov – Poster Session 3)
🔸Guidelines for Health Technology Assessment – Ministry of Health, Sultanate of Oman (Tue, 11 Nov – Poster Session 3)
🔸 Perceived Impact and Actionability of Barriers to Drug Repurposing (Tue, 11 Nov – Poster Session 4)
🔸Value Framework to Support Payer Decisions in Hemophilia in Türkiye (Tue, 11 Nov – Poster Session 4)
🔸Systematic Literature Review of AI-Based Models Predicting COPD Exacerbations (Wed, 12 Nov – Poster Session 5)
We look forward to connecting with colleagues and partners from around the world to advance evidence-based health policy, access, and value assessment.
